Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:48:41 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Q:XNCR - XENCOR INC - http://www.xencor.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
XNCR - Q1.018.65·21.000.118.95-0.12-0.6466.48,4845,87119.08  19.16  18.7230.20  16.4917:04:12Apr 0915 min RT 2¢

Recent Trades - Last 10 of 5871
Time ETExPriceChangeVolume
17:04:12Q18.95-0.121,509
16:02:35Q18.95-0.126,063
16:02:31Q18.95-0.12169
16:02:27Q18.95-0.12157
16:02:24Q18.95-0.12210
16:01:58Q18.95-0.1214
16:01:42Q18.95-0.121,741
16:01:24Q18.95-0.12268
16:01:08Q18.95-0.1217
16:00:32Q18.95-0.12219

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-09 08:01U:XNCRNews ReleaseXencor Appoints Bart Cornelissen as Chief Financial Officer
2024-02-28 16:01U:XNCRNews ReleaseXencor to Present at Upcoming Investor Conferences
2024-02-27 16:01U:XNCRNews ReleaseXencor Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-20 16:31U:XNCRNews ReleaseXencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update
2024-01-03 16:01U:XNCRNews ReleaseXencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-02 08:01U:XNCRNews ReleaseDane Leone Joins Xencor as Senior Vice President, Corporate Strategy
2023-11-21 16:01U:XNCRNews ReleaseXencor to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-07 16:01U:XNCRNews ReleaseXencor Reports Third Quarter 2023 Financial Results
2023-11-07 16:01U:XNCRNews ReleaseXencor Sells Portion of Royalties and Milestones from Ultomiris ‚ ® and Monjuvi ‚ ® to OMERS Life Sciences for $215 Million
2023-11-03 12:01U:XNCRNews ReleaseXencor Presents Preclinical Data from Multiple XmAb ‚ ® Research Programs at the SITC Annual Meeting
2023-10-31 16:01U:XNCRNews ReleaseXencor to Host Third Quarter 2023 Financial Results Webcast and Conference Call on November 7, 2023
2023-10-26 08:01U:XNCRNews ReleaseXencor Announces Planned Retirement of Chief Financial Officer John Kuch
2023-09-27 09:01U:XNCRNews ReleaseXencor to Present Multiple Posters at the SITC Annual Meeting
2023-09-19 16:01U:XNCRNews ReleaseXencor Appoints Barbara J. Klencke, M.D., to Board of Directors
2023-08-03 16:01U:XNCRNews ReleaseXencor Reports Second Quarter 2023 Financial Results
2023-07-27 08:01U:XNCRNews ReleaseXencor to Host Second Quarter 2023 Financial Results Webcast and Conference Call on August 3, 2023
2023-05-30 18:01U:XNCRNews ReleaseXencor Presents Clinical Results from Phase 1a Study of XmAb ‚ ®564 at the EULAR 2023 Congress
2023-05-08 16:01U:XNCRNews ReleaseXencor Reports First Quarter 2023 Financial Results
2023-05-01 16:01U:XNCRNews ReleaseXencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023
2023-04-26 08:01U:XNCRNews ReleaseXencor Appoints Nancy Valente, M.D., as Chief Development Officer